** Test Mode **

  0.00 (USD)

This Package provides access to the entire event

Registration Header
REGISTER TODAY!

Wave Life Sciences R&D Day

Start Date:9/28/2023

Start Time:10:00 AM EDT

Duration:90 minutes

Event Description:

Wave Life Sciences is holding a virtual analyst and investor “R&D Day”.

During the event, members from Wave's management team will discuss:

  • Applying Wave’s best-in-class, multimodal RNA medicines platform to access novel target biology
  • Extending Wave’s leadership in RNA editing, including new preclinical data for both hepatic and extra-hepatic indications
  • Wave’s approach to building depth and breadth in its emerging pipeline, while also highlighting WVE-006, the first-ever RNA editing program to enter clinical development
The event will also feature remarks from GSK leaders Tony Wood, Chief Scientific Officer, and Carolyn Buser-Doepner, PhD, Vice President of Novel Human Genetics Research Unit, on Wave’s strategic collaboration with GSK to discover and develop transformative oligonucleotide therapeutics.

If you're already registered for the analyst and investor webcast, click below:

ALREADY REGISTERED?

Speakers

Paul Bolno, MD, MBA

President and Chief Executive Officer

Anne-Marie Li-Kwai-Cheung, Mchem, MTOPRA, RAPS

Chief Development Officer

Tony Wood, PhD

Chief Scientific Officer, GSK

Carolyn Buser-Doepner, PhD

Vice President, Novel Human Genetics Research Unit, GSK

Chandra Vargeese, PhD

Chief Technology Officer, Head of Platform Discovery Sciences

Kenneth Longo, PhD

Vice President, Discovery Data Science

Ginnie Yang, PhD

Senior Vice President, Translational Medicine

Share on Facebook Share on Twitter Share on Linkedin Share through Email

Sponsors

Sponsor Image
First Name
Last Name
Email Address
Company
© 2023 All rights reserved.
Already Registered? Technical Requirements System Check Port Troubleshooting